Trending
Following unprecedented results from the RASolute 302 trial, cancer centers across the US are making daraxonrasib available to patients ahead of FDA approval. The RAS inhibitor has been in the news οΏ½...
Have a news tip or want to get in touch with our editorial team? We're here to help.
Plot C3-C Jaypee Wishtown Sector 129 Noida Uttar Pradesh 201304 India